Expert Qualifications
This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.
Bio Snapshot
- Location: MA
- BS, Biology, University of North Carolina
- PhD, Genetics, University of California, San Francisco
- Former, Scientific Education Manager, NIBR Education Office, Novartis Institutes for BioMedical Research
- Former, Program Manager, NIBR Drug Discovery Incubator, Novartis Institutes for BioMedical Research
- Former, Program Manager, Business Planning and Program Management, Alnylam Pharmaceuticals
- Former, Founder and CEO, Tremont Therapeutics
- Former, Principal Consultant, Halloran Consulting Group
- Former, Early Development Program Leader, Shire PLC
- Former, Senior Director, Shire PLC
- Former, Program Leader, Hemoglobinopathy, CRISPR Therapeutics
- Former, Executive Director, CRISPR Therapeutics
- Current, Principal, a drug development consulting company in MA
